MEMANTINE IS HIGHLY POTENT IN PROTECTING CORTICAL CULTURES AGAINST EXCITOTOXIC CELL-DEATH EVOKED BY GLUTAMATE AND N-METHYL-D-ASPARTATE

被引:97
作者
ERDO, SL
SCHAFER, M
机构
[1] Laboratory of Neurochemistry, Department of Anatomy, Georg-August University, D-3400 Göttingen
关键词
MEMANTINE; CEREBROCORTICAL CULTURES; EXCITOTOXIC CELL DEATH; NMDA (N-METHYL-D-ASPARTATE); GLUTAMATE;
D O I
10.1016/0014-2999(91)90625-Z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The capacity of memantine to protect cultured cerebrocortical cells against N-methyl-D-aspartate (NMDA)- and glutamate-induced cell death was examined. Excitotoxic cell death was evaluated by phase contrast microscopy and quantified by estimating the release of lactic dehydrogenase from damaged cells. Memantine showed a strong, long-lasting and concentration-dependent protective effect against the excitotoxic damage induced by glutamate and NMDA, with almost complete protection being attained at a memantine concentration of 0.1 mM. The present findings indicate that memantine has potential value as a drug against excitotoxic brain damage.
引用
收藏
页码:215 / 217
页数:3
相关论文
共 9 条
  • [2] COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143
  • [3] NEUROPROTECTIVE EFFECT OF MEMANTINE DEMONSTRATED INVIVO AND INVITRO
    ELNASR, MS
    PERUCHE, B
    ROSSBERG, C
    MENNEL, HD
    KRIEGLSTEIN, J
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 185 (01) : 19 - 24
  • [4] GABA DOES NOT PROTECT CEREBROCORTICAL CULTURES AGAINST EXCITOTOXIC CELL-DEATH
    ERDO, SL
    MICHLER, A
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 182 (01) : 203 - 206
  • [5] VINPOCETIN PROTECTS AGAINST EXCITOTOXIC CELL-DEATH IN PRIMARY CULTURES OF RAT CEREBRAL-CORTEX
    ERDO, SL
    NINGSHENG, C
    WOLFF, JR
    KISS, B
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 187 (03) : 551 - 553
  • [6] LACK OF EXCITOTOXIC CELL-DEATH IN SERUM-FREE CULTURES OF RAT CEREBRAL-CORTEX
    ERDO, SL
    MICHLER, A
    WOLFF, JR
    TYTKO, H
    [J]. BRAIN RESEARCH, 1990, 526 (02) : 328 - 332
  • [7] KORNHUBER J, 1989, EUROPEAN J PHARM, V166, P598
  • [8] WESEMANN W, 1983, ARZNEIMITTEL-FORSCH, V33-2, P1122
  • [9] WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210